<%BANNER%>






An Introduction to the University of Florida Clinical and Translational Science Institute
CITATION DOWNLOADS PDF VIEWER
Full Citation
STANDARD VIEW MARC VIEW
Permanent Link: http://ufdc.ufl.edu/IR00000552/00001
 Material Information
Title: An Introduction to the University of Florida Clinical and Translational Science Institute
Physical Description: Presentation
Creator: Conlon, Michael
Publication Date: August 19, 2011
 Notes
Acquisition: Collected for University of Florida's Institutional Repository by the UFIR Self-Submittal tool. Submitted by Michael Conlon.
 Record Information
Source Institution: University of Florida Institutional Repository
Holding Location: University of Florida
Rights Management: All rights reserved by the submitter.
System ID: IR00000552:00001

Downloads
Full Text

PAGE 1

An Introduction to the University of Florida Clinical and Translational Science Institute Mike Conlon, PhD COO, UF CTSI The UF CTSI is supported in part by NIH awards UL1 RR029890, KL2 RR029888 and TL1 RR029889

PAGE 2

Translational Research The UF CTSI is supported in part by NIH awards UL1 RR029890, KL2 RR029888 and TL1 RR029889 T1 T2 T3 T4 Potential Application Safe & Effective Clinical Practice Population Practice Basic Science Discovery Potential Clinical Application Basic Knowledge Theoretical Knowledge Evidence Based Guidelines Clinical Care or Intervention Health of Community or Population Applied Knowledge Efficacy Knowledge Public Health Knowledge Physiology Engineering Animal Models Phase 1 Trials Types of Research: Clinical Trials Cohort Studies Observational studies Chart reviews Comparative Effectiveness Health Services Clinical Outcomes Adoption Social determinants of health Population / outcome Health Policy Policy impact

PAGE 3

National Institutes of Health Clinical And Translational Science Awards In 2006, NIH developed the Clinical and Translational Science Award program (CTSA) led by the National Center for Research Resources CTSA works together as a national consortium of institutions sharing a common vision to improve human health by transforming the research and training environment to enhance the efficiency and quality of clinical and translational research helping scientists bridge laboratory discoveries to patient treatments and health Now fully implemented, 60 institutions transform the local, regional, and national environment to increase the efficiency and speed of clinical and translational research across the country The UF CTSI is supported in part by NIH awards UL1 RR029890, KL2 RR029888 and TL1 RR029889

PAGE 4

National Consortium of 60 Academic Health Centers The UF CTSI is supported in part by NIH awards UL1 RR029890, KL2 RR029888 and TL1 RR029889

PAGE 5

How did UF get here? In July of 2009, UF received a $26 million, five year, NIH Clinical and Translational Science Award, establishing the UF CTSI The UF Office of Research provided an additional $23 million in support The UF College of Medicine has made $70 million in commitments All 16 UF colleges effort for staff, faculty, space, equipment The result: an institute whose mission is to improve human health by accelerating the translation of scientific discoveries into the common practice of good health and health care. The UF CTSI is supported in part by NIH awards UL1 RR029890, KL2 RR029888 and TL1 RR029889

PAGE 6

A Catalyst for Collaboration UF CTSI CTSA consortium 16 UF Colleges Health Care Systems Community Partners University Partners Corporate Partners The UF CTSI is supported in part by NIH awards UL1 RR029890, KL2 RR029888 and TL1 RR029889

PAGE 7

UF CTSI Organization The UF CTSI is supported in part by NIH awards UL1 RR029890, KL2 RR029888 and TL1 RR029889

PAGE 8

Participant and Clinical Interactions Program Overarching goal Create new opportunities for patient oriented research Clinical Research Units Locations: Gainesville (UF and VA), Jacksonville, Orlando Disease expertise: Aging, Cancer, Cardiovascular, Dental, GI/ Hepatobiliary Neuromedicine Pain and Sensory Testing, Sleep Disorders, Tuberculosis and Emerging Pathogens Facilities: Phase 1: Center for Clinical trials (24 bed unit); Phase 1 3: Clinical Research Center (Gainesville and Jax ), inpatient / outpatient clinical trial needs Scientific Review Process The UF CTSI is supported in part by NIH awards UL1 RR029890, KL2 RR029888 and TL1 RR029889 Carl Pepine, MD

PAGE 9

Research Design and Analysis Overarching goal Consult, collaborate and conduct research and educate on study design and biostatistical issues in CTS. Activities Study Design clinical trials, observational studies, cohort, chart review, qualitative, epidemiologic Power Analysis Study Analysis Data presentation and visualization The UF CTSI is supported in part by NIH awards UL1 RR029890, KL2 RR029888 and TL1 RR029889 Jon Shuster, PhD

PAGE 10

Regulatory Knowledge and Research Support Overarching goal To increase accessibility of information by providing expert investigator assistance via Research Project Navigators, and provide prompt access to research and training resources ensuring rapid activation of research Services provided Trial database ( RedCap ) Forms design Quality assurance Clinical and research ethics Regulatory affairs IRB assistance Contract negotiations Billing and budgeting Technology transfer The UF CTSI is supported in part by NIH awards UL1 RR029890, KL2 RR029888 and TL1 RR029889 Wajeeh Bajwah PhD

PAGE 11

Biomedical Informatics Overarching Goal Develop and integrate clinical and research data systems to support collaborative CTS and lay groundwork for new academic program in BMI Activities Integrated Data Repository Study Registry CTSI Portal Support Systems help desk, billing, vouchers, tracking, reporting Research Discovery and Collaboration (VIVO) CTS infrastructure REDCap, Research Match, Study and Network portals, specialized system R&D The UF CTSI is supported in part by NIH awards UL1 RR029890, KL2 RR029888 and TL1 RR029889 Michael Conlon, PhD

PAGE 12

Translational Technologies and Resources Overarching Goal Develop and Provide basic science tools and services for research Cores Biorepository Genotyping Human Imaging Targeted Metabolomics Global Metabolomics Peptide Radioidionation The UF CTSI is supported in part by NIH awards UL1 RR029890, KL2 RR029888 and TL1 RR029889 Jesse Gregory, PhD

PAGE 13

Training and Professional Development Program Overarching Goal Train a new generation of multi disciplinary CTS researchers and leaders in academia, industry and government. Programs KL2 Multidisciplinary Program for Junior Faculty TL1 Pre doctoral training program Advanced Postgraduate Program in Clinical Investigation Research Coordinator Training Masters in CTS MD PhD Affiliated Programs Junior Honors Medical Program Center for Precollegiate Education and Training Center of Excellence for Regenerative Health Biotechnology HHMI Science for Life Health Science Center Training Interdisciplinary Program in Biomedical Sciences The UF CTSI is supported in part by NIH awards UL1 RR029890, KL2 RR029888 and TL1 RR029889 Marian Limacher, MD

PAGE 14

Integration of CTSI Training Programs The UF CTSI is supported in part by NIH awards UL1 RR029890, KL2 RR029888 and TL1 RR029889

PAGE 15

Community Engagement and Research Overarching Goal To promote collaborative relationships with communities to address the health and well being of community members The UF CTSI is supported in part by NIH awards UL1 RR029890, KL2 RR029888 and TL1 RR029889 Elizabeth Shenkman, PhD Mobeen Rathore, MD Linda Cottler, PhD Activities Community Advisory Boards Community Research Associates HealthStreet UF FSU Collaborative Research Program JaxHero PBRN

PAGE 16

Communications Research Overarching Goal Advance our knowledge of communication processes related to clinical care and public health Activities Studies of risk communication in surgery and genetics Studies of communications in health disparity settings The UF CTSI is supported in part by NIH awards UL1 RR029890, KL2 RR029888 and TL1 RR029889 Deborah Treise, PhD

PAGE 17

Pilot and Collaborative Projects Overarching Goal Support emerging research via institution wide RFAs for CTS, targeting junior faculty; methods (IP) development; and multi discipline, trans college initiatives. Activities Three RFAs in 2011. Seventeen awards. The UF CTSI is supported in part by NIH awards UL1 RR029890, KL2 RR029888 and TL1 RR029889 Chris Batich PhD

PAGE 18

Personalized Medicine Background Human genome project completed in 2001 personal genome will be part of their medical record, from which information can be pulled to determine disease risk or guide treatment decisions Challenge Despite the substantial number of important genetic discoveries made, there are limited examples of translation to practice UF Opportunity Build a genetic data repository Link with clinical information for research and clinical care (IDR); Clinical implementation teams; Clinical laboratory genotyping, validation, and data interpretation; Biomedical informatics; IRB and genetic counseling The UF CTSI is supported in part by NIH awards UL1 RR029890, KL2 RR029888 and TL1 RR029889 Julie Johnson, PhD

PAGE 19

Improving Clinical Research Infrastructure: Ongoing Projects 2011 UF FSU community research collaborative program Comprehensive Study Registry with T1 T4 metrics Integrated data repository Clinical Translation in Pharmacogenomics Clinical and Translational Research Building (CTRB) VIVO: Enabling National Networking of Scientists Improved efficiency for protocol submission Click commerce for IRB implementation Billing and budget tool Gator Advantage for Research subjects Cores: Biorepository, Metabolomics, Human imaging Consent for recontact and use of tissue The UF CTSI is supported in part by NIH awards UL1 RR029890, KL2 RR029888 and TL1 RR029889

PAGE 20

UF FSU Community Research Program The UF CTSI is supported in part by NIH awards UL1 RR029890, KL2 RR029888 and TL1 RR029889 Goal: Create new opportunities for practicing physicians, clinical scientists, students, and the citizens of Florida to collaborate in advancing research and education into the causes, prevention, diagnosis, treatment and cure of human disease.

PAGE 21

Comprehensive Study Registry The UF CTSI is supported in part by NIH awards UL1 RR029890, KL2 RR029888 and TL1 RR029889 Over 5700 human subject studies approved by 4 UF IRBs from 2008 to date. Web site for potential research participants to find opportunities

PAGE 22

Integrated Data Repository The UF CTSI is supported in part by NIH awards UL1 RR029890, KL2 RR029888 and TL1 RR029889 Current Researcher Dilemma no data The researcher needs to know if there are enough patients in the sponsors for approval. Researchers may need to refine a hypothesis, which is currently a challenge without access to any data. The Results?? Researcher cannot submit for a grant without realistic estimates of subject recruitment, or Research is approved and initiated, cannot be completed due to lack of appropriate subjects Wastes time and resources Places study subjects at potential risk with no research gain The Solution The Integrated Data Repository (IDR) Helps the researcher by allowing ad hoc queries for cohort discoveries, in a secure environment that protects patient privacy.

PAGE 23

Clinical Translation in Pharmacogenomics The UF CTSI is supported in part by NIH awards UL1 RR029890, KL2 RR029888 and TL1 RR029889 Clopidogrel ( Plavix ): genetic polymorphism of CYP2C19 leads to reduced ability to activate clopidigrel and increased risk of cardiovascular complication consenting; Bioethics; Communications Research Biorepository Genotyping Core Integrated Data Repository; Bioinformatics; Research IT Biomedical Informatics; Hospital IT; Epic Cardiovascular CRU; Comparative Effectiveness Research

PAGE 24

Clinical and Translational Research Building The UF CTSI is supported in part by NIH awards UL1 RR029890, KL2 RR029888 and TL1 RR029889 CTSI headquarters Ambulatory Clinical Research Center and targeted research programs Biostatistics, BMI, Epidemiology, and Health Policy Training Programs (pre and post doctoral) 80,000 ft 2 dedicated space Incorporated with Institute of Aging (NIH funded; 40,000 ft 2 ) January 2013

PAGE 25

VIVO: Enabling National Networking of Scientists NIH funded effort to create an open semantic network of information and tools regarding scientists, their interests, activities and accomplishments Seven school development consortium led by UF Fifty additional implementations underway. Dozens of partners Find people, grants, papers, data, concepts, resources, events, data, studies, projects within and across institutions http://vivoweb.org The UF CTSI is supported in part by NIH awards UL1 RR029890, KL2 RR029888 and TL1 RR029889

PAGE 26

Improving Protocol Submission Single research price list Simple confirmation of service Applies to all clinical studies using Shands services Click Commerce for IRB On line protocol submission Simplified process Budgeting tool Simplified clinical trial budget creation based on current service rates The UF CTSI is supported in part by NIH awards UL1 RR029890, KL2 RR029888 and TL1 RR029889 0 20 40 60 80 100 120 140 160 180 200 Year 0 (2008) Year 1 (2009) Year 2 (2010) Year 3 (2011) Protocol Preparation 45 35 30 30 Confirmation of Service Pricing 75 75 20 10 Approval by SAC 45 25 25 20 Approval by RAC 0 10 7 5 Approval by IRB 28 28 28 28 Number of Days Protocol Development and Approval Time

PAGE 27

For More Information On the web www.ctsi.ufl.edu Call 352 273 8700 Email info@ctsi.ufl.edu The UF CTSI is supported in part by NIH awards UL1 RR029890, KL2 RR029888 and TL1 RR029889


University of Florida Home Page
© 2004 - 2011 University of Florida George A. Smathers Libraries.
All rights reserved.

Acceptable Use, Copyright, and Disclaimer Statement
Powered by SobekCM